Yahoo Finance report covering Aemetis Inc. (AMTX) market action, institutional positioning, and fundamental catalysts.
Why AMTX Stock dropped -3.10% Today — RQD Quant Desk Flash
Aemetis Inc. (AMTX) carries a Roarable Rating of E (Strong Sell) with 28/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is AMTX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-02, Aemetis Inc. (NASDAQ: AMTX) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 28/100 at a spot price of $1.25 (-3.10% 1D, market cap $93.1M). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 5/20, and SEC Balance-Sheet Forensics 3/20. Across 270 tracked Materials issuers, AMTX ranks #243 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does AMTX compare to FSI and ARQ in the Materials sector?
▼
Within the Materials sector (Major Chemicals), AMTX carries a Roarable E (28/100 RQD), trailing P/E of N/A, gross margin of -0.4%, and ROIC of -35.0%. By comparison, FSI (Flexible Solutions International Inc. (CDA)) holds a D grade (49/100 RQD, P/E 101.5x, ROIC 8.5%, cap $79.8M) and ARQ (Arq Inc.) posts a E grade (31/100 RQD, P/E N/A, ROIC -24.6%, cap $77.3M). Among the 5-stock peer group, FSI leads on earnings multiple (101.5x) while FSI leads on capital efficiency (8.5% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for AMTX?
▼
Per AMTX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000738214), Aemetis Inc. generated $208.0M in revenue (-22.3% YoY), -$77.0M in net income, and -$22.7M in free cash flow against $259.8M in total assets and $63.9M in total debt. Key quantitative strengths: Established market leader in Materials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 0% Gross Margin
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 3/9
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
⚔️ Adversarial Opposing Case: What Could Spark a AMTX Turnaround Squeeze
While AMTX currently carries a cautious 28/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Materials with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.70) and Max Pain ($1.31) forces dealer call-delta covering toward $3.99.
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Why AMTX Stock dropped -3.10% Today — RQD Quant Desk Flash
Aemetis Inc. (AMTX) dropped -3.10% to $1.25, trading at 3% of its 52-week range ($1.17 – $3.8). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 3% of its 52-week range ($1.17 – $3.8) with RSI-14 at 35.7 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $1.25 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 0% gross margin and $0 annual free cash flow.
MarketBeat report covering Aemetis Inc. (AMTX) market action, institutional positioning, and fundamental catalysts.
TradingView report covering Aemetis Inc. (AMTX) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance UK report covering Aemetis Inc. (AMTX) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Aemetis Inc. (AMTX) market action, institutional positioning, and fundamental catalysts.
TradingView report covering Aemetis Inc. (AMTX) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Aemetis Inc. (AMTX) market action, institutional positioning, and fundamental catalysts.
https://www.dars.gov.et/ report covering Aemetis Inc. (AMTX) market action, institutional positioning, and fundamental catalysts.
CUPERTINO, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ: AMTX) announced that the company will host a conference call to review the release of its third quarter 2026 earnings report: Date: Thursday, No
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring AMTX)
- ✓Walkthrough of AMTX's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
AMTX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on AMTX today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for AMTX. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (AMTX)
1. Head-to-Head Materials Peer Comparison (AMTX vs. FSI, ARQ, LNZA, LODE)
Industry: Major Chemicals (67 Tracked Issuers)Across 270 tracked Materials securities in the Roarable RQD universe, Aemetis Inc. (AMTX) ranks #243 by composite RQD confidence (28/100, grade E) and #230 by equity capitalization ($93.1M). Within this direct 5-issuer industry benchmark cohort, FSI leads on earnings valuation at 101.5x trailing P/E, while FSI leads on capital efficiency and profitability with 8.5% ROIC and 32.6% gross margin. FSI currently holds the highest overall quantitative score in the immediate peer group at 49/100 (D) compared with AMTX at 28/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| AMTX
ACTIVE
Aemetis Inc. | E | 28/100 | — | -0.4% | -35.0% | -3.10% | $93.1M | Benchmark Subject |
| FSI Flexible Solutions International Inc. (CDA) | D | 49/100 | 101.5x | 32.6% | 8.5% | -1.44% | $79.8M | /fsi-vs-amtx → |
| ARQ Arq Inc. | E | 31/100 | — | — | -24.6% | 0.00% | $77.3M | /arq-vs-amtx → |
| LNZA LanzaTech Global Inc. | E | 26/100 | — | — | -35.0% | -8.06% | $73.0M | /lnza-vs-amtx → |
| LODE Comstock Inc. | E | 21/100 | — | -30.0% | -33.3% | -12.42% | $122.3M | /lode-vs-amtx → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000738214In its most recent audited fiscal period (FY2025, filed 2025-12-31), Aemetis Inc. (AMTX) reported GAAP revenue of $208.0M (-22.3% vs. FY2024 revenue of $267.6M , and +169.4% cumulative change since FY2023) , GAAP net income of -$77.0M, operating cash flow of $3.3M, and free cash flow of -$22.7M (+57.2% YoY). On the balance sheet, AMTX closed FY2025 with $259.8M in total assets against $63.9M in total debt (Altman Z-Score: N/A, Piotroski F-Score: 3/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $208.0M | -$77.0M | $3.3M | -$22.7M | $259.8M | $63.9M |
| FY2024 (FY) | 2024-12-31 | $267.6M | -$87.5M | -$32.9M | -$53.2M | $259.3M | $247.5M |
| FY2023 (FY) | 2023-12-31 | $77.2M | -$46.4M | $13.8M | $13.8M | — | — |
3. AMTX Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs AMTX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-02, Aemetis Inc. (NASDAQ: AMTX) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 28/100 at a spot price of $1.25 (-3.10% 1D, market cap $93.1M). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 5/20, and SEC Balance-Sheet Forensics 3/20. Across 270 tracked Materials issuers, AMTX ranks #243 in composite RQD confidence.
How does AMTX compare to FSI and ARQ in the Materials sector?
Within the Materials sector (Major Chemicals), AMTX carries a Roarable E (28/100 RQD), trailing P/E of N/A, gross margin of -0.4%, and ROIC of -35.0%. By comparison, FSI (Flexible Solutions International Inc. (CDA)) holds a D grade (49/100 RQD, P/E 101.5x, ROIC 8.5%, cap $79.8M) and ARQ (Arq Inc.) posts a E grade (31/100 RQD, P/E N/A, ROIC -24.6%, cap $77.3M). Among the 5-stock peer group, FSI leads on earnings multiple (101.5x) while FSI leads on capital efficiency (8.5% ROIC).
What are the biggest fundamental strengths and SEC risk factors for AMTX?
Per AMTX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000738214), Aemetis Inc. generated $208.0M in revenue (-22.3% YoY), -$77.0M in net income, and -$22.7M in free cash flow against $259.8M in total assets and $63.9M in total debt. Key quantitative strengths: Established market leader in Materials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is AMTX trading relative to its 50-day, 200-day, and 52-week technical levels?
AMTX last traded at $1.25 (-3.10% on volume of 634,861 shares), positioning the stock -26.47% below its 50-day simple moving average ($1.70) and -36.55% below its 200-day simple moving average ($1.97). Across its 52-week range of $1.17 to $3.80, AMTX sits at the 3.0% percentile with a 14-day RSI of 35.7 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.09 to $1.41).
AMTX Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is AMTX stock moving today?
Why AMTX Stock dropped -3.10% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
AMTX — Aemetis Inc.: What the Facts Mean to a Prospective Investor
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, AMTX carries an RQD Score of 28 and a letter grade of E, labeled "Roarable Strong Sell — Forensic Risk / Avoid." The five pillars score as follows: Fundamental Cash Engine 9/20 (ROIC -35%; FCF yield -24.42%), Whale 13F Flow 3/20, Insider Conviction 3/20, Macro Regime Fit 5/20 (Beta 1.0), and Forensic Balance Sheet 8/20 (Altman Z 2.5; Piotroski F 3/9; Debt/Equity 0.5). Every pillar sits well below its 20-point maximum. The weakest signals are institutional and insider positioning, which are the pillars that would ordinarily corroborate a thesis from outside the company; the cash-engine pillar is also depressed by negative returns on capital and negative free cash flow yield. For a prospective investor evaluating the stock today, the rating frames the setup as one where the reported economics and the ownership signals both point away from the stock, with the balance sheet scored as a forensic concern rather than a strength. Upside drivers would need to come from outside the rated data, and the source data does not establish any such driver. The rating is an analytical summary of the supplied figures and is not personalized financial advice.
Business
Aemetis Inc. (AMTX) is a NASDAQ-listed issuer classified in the Materials sector and the Major Chemicals industry, per the profile section. The source data does not describe its specific products, customers, or revenue model beyond the sector and industry classification. The reported revenue figures (see Financial Trend) are the only operating disclosure available, and they are not broken down by product or customer in the source data.
Financial Trend
| Period | Revenue | Operating Income | Net Income | EPS | FCF | Cash | Debt |
|---|---|---|---|---|---|---|---|
| FY 2025 | $208.0M | $-37.2M | $-77.0M | N/A | $-22.7M | $4.9M | $63.9M |
| FY 2024 | $267.6M | $-40.4M | $-87.5M | N/A | $-53.2M | $0.9M | $247.5M |
| FY 2023 | $77.2M | $-37.4M | $-46.4M | N/A | $13.8M | N/A | N/A |
Per the market data, gross margin is -0.4%, operating margin -17.9%, and net margin -37%, with ROIC at -35%. Per the Roarable RQD rating, the Altman Z-Score is 2.5, the Piotroski F-Score is 3/9, and Debt/Equity is 0.5. Reported net losses appear in all three periods, and free cash flow was negative in FY 2025 and FY 2024 after a positive figure in FY 2023. Debt in the source data declined from $247.5M in FY 2024 to $63.9M in FY 2025, while reported cash was $4.9M at FY 2025.
Recent Catalysts & News Wire Analysis
Per the recent news section, the wire items reference a biogas digester start-up ("Aemetis Begins Operation of Two New Biogas Digesters"), a weekly recap citing "$22.8M 45Z credits and Keyes RNG station," a Q3'26 earnings revenue estimate of 74.20M USD, and two MarketBeat items reporting the stock price breaking below its 200-day moving average. All items are tagged with a YELLOW light and MARKET WIRE impact label. The source data does not provide the content of these reports beyond their headlines and summaries, so their substance cannot be confirmed. Risk watch items include the sub-200-day moving average crossovers and the negative reported margins. Per the Butterfly Supply-Chain Graph, the supply chain is recorded as "NONE," with no butterfly links and no proprietary signals.
Butterfly Effect: 2nd-Order Supply-Chain & Sector Ripples
Per the Butterfly Supply-Chain Graph, no upstream or downstream dependencies, sector correlations, or proprietary signal links are recorded. The source data therefore does not establish any 2nd-order ripple effects. A prospective investor should note the absence of mapped supply-chain links as a gap in the analysis rather than as evidence of independence.
Open Questions
- What are the specific products, customers, and revenue drivers behind the reported FY 2024 and FY 2025 revenue figures?
- What is the basis for the reported cash of $4.9M against debt of $63.9M in FY 2025, and what is the debt maturity profile?
- What drove the decline in reported debt from $247.5M to $63.9M between FY 2024 and FY 2025?
- What are the content and financial implications of the 45Z credits and biogas digester news referenced in the wire?
- Why are EPS, P/E, and forward estimates unavailable, and what is the current share count?
AMTX Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Aemetis Inc. (AMTX) • Click "Debate This Headline" to argue it in the Roar Pit below
Yahoo Finance report covering Aemetis Inc. (AMTX) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Aemetis Inc. (AMTX) market action, institutional positioning, and fundamental catalysts.
TradingView report covering Aemetis Inc. (AMTX) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance UK report covering Aemetis Inc. (AMTX) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Aemetis Inc. (AMTX) market action, institutional positioning, and fundamental catalysts.
TradingView report covering Aemetis Inc. (AMTX) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Aemetis Inc. (AMTX) market action, institutional positioning, and fundamental catalysts.
https://www.dars.gov.et/ report covering Aemetis Inc. (AMTX) market action, institutional positioning, and fundamental catalysts.
AMTX Bull vs. Bear Conversation Board — What's Your Call at $1.25?
🔥 Official Bull vs. Bear Debate: Is AMTX (E • RQD 28/100) a Buy at $1.29?
Welcome to the AMTX (Aemetis Inc.) Roar Pit. Current RQD Composite is 28/100 (Roarable Strong Sell — Forensic Risk / Avoid) in Major Chemicals. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
Pump the brakes on AMTX — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on AMTX, but look at what you are paying: current EV/EBITDA multiples with -0.4% gross margins. Unless Aemetis Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
AMTX cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on AMTX, the market is fixating on short-term headline noise in Major Chemicals and ignoring the balance sheet and cash flow trajectory. At $1.29 (52-wk range $1.17 - $3.80), any beat on forward guidance forces shorts and underweight funds to chase.